NHS Framework Colorectal Cancer Drugs (See description below)
key details
| Status | active |
|---|---|
| Category (CPV) | 33690000 +1 more |
| Region | East Midlands, East of England, London, North East, North West, South East, South West, West Midlands, Yorkshire and the Humber |
| Deadline | 1 Sept 2020 |
| Contract start | 1 Dec 2020 |
| Contract end | 30 Nov 2022 |
| Procedure | open |
| SME suitable | No |
| OCID | ocds-b5fd17-0c5a12da-1a60-4552-8de6-e57234f93539 |
description
The NHS Commissioning Board (operating under the name of NHS England and NHS Improvement) looks to establish an NHS Framework agreement (on behalf of NHS Trusts) for the supply of drugs licensed specifically to target epidermal growth factor receptor (EGFR)-expressing, RAS wild-type metastatic colorectal cancer.
Ref: Tender C1485 Period of framework: 1st December 2020* to 30th November 2022 with an option to extend (at the Authority's discretion) for a further period (or periods) up to a total of 12 months (i.e. total possible framework duration of 36 months)
All documents can be found at:health.atamis.co.uk
documents
- https://www.contractsfinder.service.gov.uk/Notice/bc50321f-f535-4c9b-999b-216db33abd41 , tenderNotice
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 25 Nov 2020 | Tender (tender) | · | 7bab0bf1-b9b0-4ff4-96fc-575a944257f1-395880 |
more from Health Family
- XMNPROGYDC · £4,198,347 · 17 Mar 2021
- XMNPROGQ1P7 · £1,884,298 · 22 Feb 2021
- XMNPROGJANQ1P4 · £4,886,777 · 2 Feb 2021
- XMNPROGQ1P5 · £1,167,355 · 2 Feb 2021
- XMNPROGQ1P3 · £4,592,562 · 29 Jan 2021
- XMNPROGQ1 · £13,037,603 · 28 Jan 2021
- XMNPROGQ1P2 · £3,864,876 · 25 Jan 2021
- XMNPROGJAN3 · £1,301,653 · 21 Jan 2021
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Labs Consumables ePunchout 3 · UNIVERSITY OF SOUTHAMPTON · £1,500,000
- Supply of reagents · NEWCASTLE UNIVERSITY · £177,420
- Supply of reagents · NEWCASTLE UNIVERSITY · £37,829
- Supply of reagents · NEWCASTLE UNIVERSITY · £36,485
- Supply of Antibodies · NEWCASTLE UNIVERSITY · £23,108
- Suplly of Reagents · NEWCASTLE UNIVERSITY · £23,212
- Controlled drugs · London Ambulance Service NHS Trust · £154,225
- IonOptix cardiomyocyte fluo-3 calcium and contractility acquisition system. · UNIVERSITY OF NOTTINGHAM (THE) · £67,737
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.